Pharmacology Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Pharmacology stocks.

Pharmacology Stocks Recent News

Date Stock Title
Oct 2 JNJ Johnson & Johnson's Options: A Look at What the Big Money is Thinking
Oct 2 JNJ Johnson & Johnson's Erleada Shows Improved Overall Survival In Prostate Cancer Patients Compared To Pfizer's Drug
Oct 2 JNJ J&J prostate cancer therapy outperforms in real-world study
Oct 2 JNJ ERLEADA® (apalutamide) demonstrates statistically significant and clinically meaningful improvement in overall survival compared to enzalutamide in patients with metastatic castration-sensitive prostate cancer
Oct 2 JNJ J&J to invest over $2B to build new North Carolina plant
Oct 1 ARCT Unveiling 3 Analyst Insights On Arcturus Therapeutics
Oct 1 JNJ U.S. port strike expected to have limited impact on healthcare supply chain: HHS
Oct 1 JNJ 55-Year-Old Who Reached $3,900 Per Month Income In Just 5 Years Shares Portfolio: Top 9 Stocks And ETFs
Oct 1 JNJ J&J to invest over $2 billion for new manufacturing facility in North Carolina
Oct 1 ARCT ARCT Stock Up as Updated COVID-19 Jab Betters PFE & BNTX's Comirnaty
Oct 1 JNJ Johnson & Johnson (NYSE:JNJ) is a favorite amongst institutional investors who own 73%
Oct 1 JNJ Johnson & Johnson launches TECNIS Odyssey intraocular lens in US
Oct 1 JNJ J&J drops 340B rebate plan following government pressure
Sep 30 JNJ J&J submits supplemental BLA for Darzalex Faspro to FDA
Sep 30 JNJ J&J Backtracks on Plan Aimed at Hospital Drug-Discount Program
Sep 30 JNJ Johnson & Johnson files for U.S. FDA approval of DARZALEX FASPRO®-based quadruplet regimen for newly diagnosed multiple myeloma patients for whom transplant is not planned
Sep 30 NKTR Nektar rises 11% as BTIG initiates buy rating on autoimmune disorders asset
Sep 30 JNJ J&J clinches EC approval for first single-pill PAH combo
Sep 30 JNJ 80 Hedge Funds Hold Stakes in Johnson & Johnson (JNJ) as of Q2 2024
Sep 30 ARCT Arcturus Therapeutics/CSL Partnered COVID-19 Vaccine Surpasses Pfizer's Comirnaty Shot, Even At Lower Doses
Pharmacology

Pharmacology is the branch of biology concerned with the study of drug action, where a drug can be broadly defined as any man-made, natural, or endogenous (from within the body) molecule which exerts a biochemical or physiological effect on the cell, tissue, organ, or organism (sometimes the word pharmacon is used as a term to encompass these endogenous and exogenous bioactive species). More specifically, it is the study of the interactions that occur between a living organism and chemicals that affect normal or abnormal biochemical function. If substances have medicinal properties, they are considered pharmaceuticals.
The field encompasses drug composition and properties, synthesis and drug design, molecular and cellular mechanisms, organ/systems mechanisms, signal transduction/cellular communication, molecular diagnostics, interactions, toxicology, chemical biology, therapy, and medical applications and antipathogenic capabilities. The two main areas of pharmacology are pharmacodynamics and pharmacokinetics. Pharmacodynamics studies the effects of a drug on biological systems, and Pharmacokinetics studies the effects of biological systems on a drug. In broad terms, pharmacodynamics discusses the chemicals with biological receptors, and pharmacokinetics discusses the absorption, distribution, metabolism, and excretion (ADME) of chemicals from the biological systems. Pharmacology is not synonymous with pharmacy and the two terms are frequently confused. Pharmacology, a biomedical science, deals with the research, discovery, and characterization of chemicals which show biological effects and the elucidation of cellular and organismal function in relation to these chemicals. In contrast, pharmacy, a health services profession, is concerned with application of the principles learned from pharmacology in its clinical settings; whether it be in a dispensing or clinical care role. In either field, the primary contrast between the two are their distinctions between direct-patient care, for pharmacy practice, and the science-oriented research field, driven by pharmacology.
The origins of clinical pharmacology date back to the Middle Ages in Avicenna's The Canon of Medicine, Peter of Spain's Commentary on Isaac, and John of St Amand's Commentary on the Antedotary of Nicholas. Clinical pharmacology owes much of its foundation to the work of William Withering. Pharmacology as a scientific discipline did not further advance until the mid-19th century amid the great biomedical resurgence of that period. Before the second half of the nineteenth century, the remarkable potency and specificity of the actions of drugs such as morphine, quinine and digitalis were explained vaguely and with reference to extraordinary chemical powers and affinities to certain organs or tissues. The first pharmacology department was set up by Rudolf Buchheim in 1847, in recognition of the need to understand how therapeutic drugs and poisons produced their effects.Early pharmacologists focused on natural substances, mainly plant extracts. Pharmacology developed in the 19th century as a biomedical science that applied the principles of scientific experimentation to therapeutic contexts. Today pharmacologists use genetics, molecular biology, biochemistry, and other advanced tools to transform information about molecular mechanisms and targets into therapies directed against disease, defects or pathogens, and create methods for preventative care, diagnostics, and ultimately personalized medicine.

Browse All Tags